AxoGen, Inc.
AXGN
$34.00
$3.019.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.30% | 6.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.30% | 6.04% | |||
| Cost of Revenue | 9.98% | -3.79% | |||
| Gross Profit | -3.44% | 9.46% | |||
| SG&A Expenses | 14.48% | 9.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.78% | 5.78% | |||
| Operating Income | -611.09% | 14.35% | |||
| Income Before Tax | -1,958.19% | 22.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,958.19% | 22.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,958.19% | 22.28% | |||
| EBIT | -611.09% | 14.35% | |||
| EBITDA | -320.90% | 7.28% | |||
| EPS Basic | -1,961.84% | 20.63% | |||
| Normalized Basic EPS | -1,962.11% | 20.25% | |||
| EPS Diluted | -2,930.00% | 0.00% | |||
| Normalized Diluted EPS | -2,065.56% | 20.00% | |||
| Average Basic Shares Outstanding | -0.02% | 0.94% | |||
| Average Diluted Shares Outstanding | -5.30% | 2.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||